Literature DB >> 18157462

The use of exhaled nitric oxide monitoring in primary care asthma clinics: a pilot study.

Kevin Gruffydd-Jones1, Sabbi Ward, Carol Stonham, Tatiana V Macfarlane, Mike Thomas.   

Abstract

AIM: Although asthma is defined as a chronic inflammatory disease, inflammation is rarely assessed. The fraction of exhaled nitric oxide (FeNO) is a biomarker of airways inflammation. We assessed the feasibility of FeNO monitoring in general practice.
METHODS: Prospective observational study of volunteers attending primary care asthma clinics. Consenting subjects were seen at their own surgery for 2-weekly reviews over 12 weeks, with assessment of FeNO, lung function, symptoms and health status.
RESULTS: 22 adults and 15 children provided informed consent. Two subjects were unable to perform the FeNO expiratory manoeuvre. In the remaining subjects, measurements conforming to highest ERS/ATS recommendations were made on 211 of 236 occasions, and on 21 further occasions acceptable readings were made. Acceptability was high to subjects and staff. Correlations between FeNO readings and other parameters were weak and non-significant except for statistically significant correlation between longitudinal FeNO changes and changes in lung function (r= -0.33, p<0.001) and health status (r= -0.22, p=0.022).
CONCLUSIONS: Exhaled nitric oxide monitoring is technically feasible and acceptable to staff and patients within the context of a primary care asthma clinic.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18157462      PMCID: PMC6634246          DOI: 10.3132/pcrj.2007.00076

Source DB:  PubMed          Journal:  Prim Care Respir J        ISSN: 1471-4418


  4 in total

1.  Spirometry and FeNO testing for asthma in children in UK primary care: a prospective observational cohort study of feasibility and acceptability.

Authors:  David Lo; Caroline Beardsmore; Damian Roland; Matthew Richardson; Yaling Yang; Lesley Danvers; Andrew Wilson; Erol A Gaillard
Journal:  Br J Gen Pract       Date:  2020-10-29       Impact factor: 5.386

2.  Exhaled nitric oxide in asthma: progress since the introduction of standardized methodology.

Authors:  Natalia M Grob; Raed A Dweik
Journal:  J Breath Res       Date:  2008-09       Impact factor: 3.262

3.  Qualitative study on perceptions of use of Fractional Exhaled Nitric Oxide (FeNO) in asthma reviews.

Authors:  Marta Santillo; Ben Ainsworth; Michelle Helena Van Velthoven; Lucy Yardley; Mike Thomas; Kay Wang; Sarah Tonkin-Crine
Journal:  NPJ Prim Care Respir Med       Date:  2022-03-21       Impact factor: 2.871

4.  Not all children with under-control asthma are controlled.

Authors:  G Ricci; A Dondi; E Calamelli; V Dell'omo; L Pagliara; T Belotti; M Masi
Journal:  Open Respir Med J       Date:  2008-02-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.